RNA-modulating therapeutics: personalized exon skipping for duchenne muscular dystrophy
RNA-modulating therapeutics: personalized exon skipping for duchenne muscular dystrophy
About this item
Full title
Author / Creator
Publisher
Mary Ann Liebert, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Mary Ann Liebert, Inc
Subjects
More information
Scope and Contents
Contents
Duchenne muscular dystrophy (DMD) patients suffer from a progressive, severe muscle-wasting disease due to frame-disrupting mutations in the DMD gene and a complete loss of functional dystrophin. Antisense oligonucleotide compounds (AONs) have recently shown therapeutic promise for DMD patients. By inducing specific exon skipping during mRNA splici...
Alternative Titles
Full title
RNA-modulating therapeutics: personalized exon skipping for duchenne muscular dystrophy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_20239163
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20239163
Other Identifiers
ISSN
1043-0342